Curium Pharma Is A Global Leader In Nuclear Medicinefocusing On Radiopharmaceuticals For Diagnostic And Therapeutic Applicationsestablished In 2017 From The Merger Of Iba Molecular And Mallinckrodt Nuclear Medicine Llcthe Company Has A Rich History In Radiopharmaceutical Innovation Dating Back To The 1960Sheadquartered In Parisfrancecurium Operates In Over 60 Countries And Serves More Than 14 Million Patients Each Yearprimarily In Cancer Diagnostics And Treatment The Company Develops And Manufactures Radiopharmaceuticals Used In Medical Imagingsuch As Pet And Spect Scansas Well As Targeted Therapiescurium S Mission Is To Advance Nuclear Medicine To Enhance Patient Careemphasizing Qualityreliabilityand Innovationit Serves Healthcare Providersincluding Hospitals And Diagnostic Centersand Plays A Crucial Role In Oncology Workflows By Aiding In Early Disease Detection And Personalized Treatment Plans
